Using genetic information to select treatment for patients with heart failure: has the time come?

Author： Fiuzat Mona Felker G Michael Donahue Mark P O’’Connor Christopher M

ISSN： 1741-0541

Source： Personalized Medicine, Vol.6, Iss.4, 2009-07, pp. : 385-392

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leaders argue that the time has come for report cards on treatment centers

ALCOHOLISM AND DRUG ABUSE WEEKLY, Vol. 30, Iss. 3, 2018-01 ,pp. : 1-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Thalidomide Treatment in Heart Failure Patients

Cardiology, Vol. 108, Iss. 4, 2006-11 ,pp. : 237-242

Karger

Access to resources Recommend Favorite

NAOMI—Her Time Has Come

By Schechter M.T.

Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 79, Iss. 2, 2002-06 ,pp. : 164-165

Springer Publishing Company

Access to resources Recommend Favorite

Problems, Pitfalls and Encouraging Information on Patients with Diabetes and Heart Failure

Cardiology, Vol. 134, Iss. 4, 2016-04 ,pp. : 411-412

Karger

Access to resources Recommend Favorite

Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials

Cardiology, Vol. 130, Iss. 2, 2015-01 ,pp. : 69-81

Karger

Access to resources Recommend Favorite